Who are Cognision's investors?

Cognision's investors include Keyhorse Capital.

Cognision

1 known investors

Find your way into Cognision

Cognision develops an objective measurement system for evaluating patients with cognitive disorders including concussion, mTBI, and dementia, serving clinicians, pharmaceutical companies, and researchers through brain-based biomarkers and qEEG/ERP testing.

AI & Machine Learning Digital Health Medical Devices

Investors · 1

Keyhorse CapitalLexingtonvia Kelby Price · inferred

Competitors · 1

by search overlap

Cognito TX26 shared keywordsCognito Therapeutics develops Spectris, a non-invasive sensory stimulation technology platform to treat neurodegenerative diseases including Alzheimer's by improving cognitive performance. The company serves patients with neurodegenerative conditions and aims to transform disease management through clinical-to-commercial pathways in the neurological therapeutics sector.

Companies competing with Cognision for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Cognitive-focused dev Neuronetrix raises $2m - MassDevicemassdevice.com · Jul 2018

Frequently asked questions

What does Cognision do?: Cognision develops an objective measurement system for evaluating patients with cognitive disorders including concussion, mTBI, and dementia, serving clinicians, pharmaceutical companies, and researchers through brain-based biomarkers and qEEG/ERP testing.
Who are Cognision's investors?: Cognision's investors include Keyhorse Capital.